Jennifer K. Mooi
Melbourne, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Differentiation grade is highly concordant between matched primary and metastatic colorectal cancer.
Differentiation grade is highly concordant between matched primary and metastatic colorectal cancer.
Journal: Clinical & experimental metastasis
Published: July 05, 2025
Early-stage multi-cancer detection through a plasma extracellular vesicle protein signature.
Journal: Cell reports. Medicine
Published: December 28, 2024
Model systems and unique biological features of high and low-grade colorectal cancer (CRC) revealed by xenografting 84 human CRC cell lines.
Journal: Communications biology
Published: October 30, 2024
Addressing disparities in health outcomes for patients with advanced pancreatic cancer and limited English proficiency.
Journal: Asia-Pacific journal of clinical oncology
Published: September 24, 2023
The Role of Stereotactic Ablative Body Radiotherapy in Renal Cell Carcinoma.
Journal: European urology
Published: March 25, 2022
Epithelial de-differentiation triggered by co-ordinate epigenetic inactivation of the EHF and CDX1 transcription factors drives colorectal cancer progression.
Journal: Cell death and differentiation
Published: December 30, 2021
Predictive value of chromosome 18q11.2-q12.1 loss for benefit from bevacizumab in metastatic colorectal cancer: A post hoc analysis of the randomized phase III-trial AGITG-MAX.
Journal: International journal of cancer
Published: October 26, 2021
VEGF-A, VEGFR1 and VEGFR2 single nucleotide polymorphisms and outcomes from the AGITG MAX trial of capecitabine, bevacizumab and mitomycin C in metastatic colorectal cancer.
Journal: Scientific reports
Published: July 02, 2021
Dual Antiangiogenesis Agents Bevacizumab Plus Trebananib, without Chemotherapy, in First-line Treatment of Metastatic Colorectal Cancer: Results of a Phase II Study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 20, 2020
A phase I/II study of stereotactic radiotherapy and pembrolizumab for oligometastatic renal tumours (RAPPORT): Clinical trial protocol.
Journal: Contemporary clinical trials communications
Published: March 15, 2020
Last Updated: 09/26/2026